drug · antibody
setrusumab
Phase 3updated 6mo agoby $RARE Ultragenyx Pharmaceutical Inc.🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
targets
Sclerostin
all catalysts(0)
nothing on the calendar yet
Trials studying setrusumab
- phase3Setrusumab vs Placebo for Osteogenesis Imperfecta
- phase3Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta
- phase3Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta
- phase2Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis Imperfecta
- phase2A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804
News(3)
- AstraZeneca, Calidi, Tempest make significant workforce cutsFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 19h ago
- Ultragenyx shrinks workforce and axes assets to halve R&D spendUltragenyx is laying off 20% of its workforce and axing drug development programs to cut its annual R&D budget to half of the amount it spent in 2025.fiercebiotech · 13d ago
- Milestone Sanfilippo nod helps Ultragenyx regroup after tough Angelman defeatThe recent FDA approval of Fayuvi for a rare, childhood neurodegenerative disease was “particularly special” for Ultragenyx CEO Emil Kakkis. It could also, along with an August nod for another gene…biospace · 1mo ago
Data sources
last refreshed 43m ago
Found something off?
comments(0)
5-min edit window · permanent after that